Understanding motivations for large US cannabis firms' participation in the cannabis space: Qualitative study exploring views of key decision-makers.
Cannabis
Cannabis firms
qualitative research
usage preferences
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
27
09
2019
revised:
14
01
2020
accepted:
15
01
2020
pubmed:
15
2
2020
medline:
30
7
2021
entrez:
15
2
2020
Statut:
ppublish
Résumé
Large for-profit firms supply the majority of US state-legal cannabis stores and some firms have attempted to shape cannabis-related policies. Understanding firms' motivations for participation in the cannabis space is critical, given firms' possible links to cannabis usage patterns. Key decision-makers (KDM) in the cannabis space may have information unavailable to lower ranking staff, and may influence firm decision-making and consequently US cannabis usage practises. We present the findings of a qualitative study investigating the views of KDMs in the cannabis market, on large cannabis firms' motivations for participation in the space. Data were collected through 37 semi-structured interviews with a convenience sample of KDMs in the US cannabis space, representing both for-profit and non-profit organisations. Thematic analysis, with an inductive approach, was used to analyse the data. KDMs reported three non-exclusive motivations for large cannabis firms' participation in the space; to seek profit, to mitigate social inequity and to provide cannabis as medicine. Within the theme relating to profit, findings suggest that for-profit and non-profit organisations in the space may be cognisant of the other's goals, representing a symbiotic relationship. We suggest that firms may have reasons to enter the space not necessarily centred on increasing use. Although non-profits and for-profits have different agendas, the bottom line for both groups is to expand access. Policy-makers should be aware of that fact, and set policies which consider the two groups as a unified whole.
Substances chimiques
Medical Marijuana
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
347-355Informations de copyright
© 2020 Australasian Professional Society on Alcohol and other Drugs.
Références
Hall WUS. Policy responses to calls for the medical use of Cannabis. Yale J Biol Med 2015;88:257-64.
NCSL.org. State Medical Marijuana Laws [Internet]. 2018. Available at: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (accessed 10 January 2019)
Fiorillo S. Where Can You Legally Get Cannabis? [Internet]. The Street. 2018. Available at: https://www.thestreet.com/lifestyle/health/states-with-legalized-marijuana-14581737 (accessed 16 August 2018).
Lopez G. Marijuana is Illegal Under Federal Law Even in States that Legalize it - Vox [Internet]. 2018. Available at: https://www.vox.com/identities/2018/8/20/17938372/marijuana-legalization-federal-prohibition-drug-scheduling-system (accessed 10 January 2019)
Angell T. Senators Include Medical Marijuana Protections In Justice Department Bill [Internet]. Forbes. 2018 [cited 2018 Aug 16]. Available from: https://www.forbes.com/sites/tomangell/2018/06/12/senators-include-medical-marijuana-protections-in-justice-department-bill/
Paxhia E. Guest Column: The 5 Types of Cannabis Companies Most Likely to Get Investment Money [Internet]. Marijuana Business Daily. 2014. Available at: https://mjbizdaily.com/guest-column-5-types-of-cannabis-companies-that-are-most-likely-to-get-investment-money/ (accessed 10 January 2019)
Green Growth Brands. A Guide to the Variety of Cannabis Companies [Internet]. GGB. 2018. Available at: https://www.greengrowthbrands.com/blog/a-guide-to-the-varieties-of-cannabis-companies/ (accessed 10 January 2019)
The Arcview Group. The State of Legal Marijuana Markets - 3rd Edition [Internet]. The Arcview Group; 2015. Available at: https://arcviewgroup.com/product/6th-edition/ (accessed 13 December 2013)
Reisinger D. The Legal Marijuana Industry Is Soaring-And 2019 Could Be Its Best Year Yet [Internet]. Fortune. 2018. Available at: http://fortune.com/2018/12/27/legal-marijuana-industry-sales/ (accessed 8 February 2019)
McGee S. Paypal founder Peter Thiel Becomes Marijuana's First Big Investor. The Guardian [Internet]. 2015. Available at: http://www.theguardian.com/business/2015/jan/08/cannabis-investor-peter-theil-paypal-founder (accessed 13 November 2017)
Blanco C, Hasin DS, Wall MM et al. Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA Psychiat 2016;73:388-95.
Han B, Hedden S, Lipari R, Copello E, Kroutil L. Receipt of services for behavioral health problems: results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2015.
Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction 2008;103:969-76 discussion 977-8.
Cerdá M, Wall M, Keyes KM, Galea S, Hasin D. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend 2012;120:22-7.
Caulkins JP. Non-profit Motive. Washington Monthly [Internet]. 2014. Available at: https://washingtonmonthly.com/magazine/marchaprilmay-2014/non-profit-motive/ (accessed 21 November 2018)
Subritzky T, Pettigrew S, Lenton S. Issues in the implementation and evolution of the commercial recreational cannabis market in Colorado. Int J Drug Policy 2016;27:1-12.
Barry RA, Glantz S. A public health framework for legalized retail marijuana based on the US experience: avoiding a new tobacco industry. PLoS Med 2016;13:e1002131.
D'Amico EJ, Miles JN, Tucker JS. Gateway to curiosity: medical marijuana ads and intention and use during middle school. Psychol Addict Behav 2015;29:613-9.
Caulkins JP, Bao Y, Davenport S et al. Big data on a big new market: insights from Washington State's legal cannabis market. Int J Drug Policy 2018;57:86-94.
Chan GC, Hall W, Freeman TP, Ferris J, Kelly AB, Winstock A. User characteristics and effect profile of butane hash oil: an extremely high-potency cannabis concentrate. Drug Alcohol Depend 2017;178:32-8.
Richter KP, Levy S. Big marijuana-lessons from big tobacco. N Engl J Med 2014;371:399-401.
Neuman M, Bitton A, Glantz S. Tobacco industry strategies for influencing European Community tobacco advertising legislation. Lancet 2002;359:1323-30.
World Health Organization. Tobacco Industry Interference with Tobacco Control. 2009. Available at: https://escholarship.org/uc/item/98w687x5 (accessed 27 November 2019)
Goldstein AO, Bearman NS. State tobacco lobbyists and organizations in the United States: crossed lines. Am J Public Health 1996;86:1137-42.
White J, Bero LA. Public health under attack: the American stop smoking intervention study (ASSIST) and the tobacco industry. Am J Public Health 2004;94:240-50.
Hall W, Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 2016;111:1764-73.
Hall W, Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther 2015;97:607-15.
Drug Policy Alliance. Marijuana Legalization and Regulation [Internet]. Drug Policy Alliance. 2018. Available at: http://www.drugpolicy.org/issues/marijuana-legalization-and-regulation (accessed 2 December 2018)
Todd T. The benefits of marijuana legalization and regulation. Berkeley J Crim Law 2018;23:6.
Bennett EA. Extending ethical consumerism theory to semi-legal sectors: insights from recreational cannabis. Agric Hum Values 2018;35:295-317.
Bottorff JL, Bissell LJ, Balneaves LG, Oliffe JL, Capler NR, Buxton J. Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduct J 2013;10:2.
Garden Remedies Inc. Garden Remedies' Catalyst Mentoring Program Gives Massachusetts Cannabis Entrepreneurs a Hand Up [Internet]. 2018. Available at: https://www.prnewswire.com/news-releases/garden-remedies-catalyst-mentoring-program-gives-massachusetts-cannabis-entrepreneurs-a-hand-up-300711517.html (5 November 2018).
Caulkins JP, Kilmer B, Kleiman MA et al. Considering marijuana legalization: insights for Vermont and other jurisdictions. Santa Monica, CA: RAND Corporation, 2015.
GBI Research. First Big Pharma Company to Distribute Medical Cannabis Products [Internet]. Pharmaceutical Technology. 2018. Available at: https://www.pharmaceutical-technology.com/comment/first-big-pharma-company-distribute-medical-cannabis-products/ (accessed 13 December 2018).
Caulkins JP. Recognizing and regulating cannabis as a temptation good. Int J Drug Policy 2017;42:50-6.
Jain NK, Lahiri S, Hausknecht DR. Emerging market multinationals' location choice: the role of firm resources and internationalization motivations. Eur Bus Rev 2013;25:263-80.
Room R, Fischer B, Hall W, Lenton S. Cannabis policy: moving beyond stalemate. Oxford, England: Oxford University Press, 2010.
Barry RA, Hiilamo H, Glantz SA. Waiting for the opportune moment: the tobacco industry and marijuana legalization. Milbank Q 2014;92:207-42.
Papadakis VM, Barwise P. How much do CEOs and top managers matter in strategic decision-making? Br J Manag 2002;13:83-95.
Delaney KJ. Methodological dilemmas and opportunities in interviewing organizational elites. Sociol Compass 2007;1:208-21.
Indiana University Center for Postsecondary Research. Carnegie Classification of Institutions of Higher Education. 2018.
Harvey WS. Methodological approaches for interviewing elites. Geogr Compass 2010;4:193-205.
Belackova V, Tomkova A, Zabransky T. Qualitative research in Spanish cannabis social clubs:“the moment you enter the door, you are minimising the risks”. Int J Drug Policy 2016;34:49-57.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
Aguinaldo JP. Qualitative analysis in gay men's health research: comparing thematic, critical discourse, and conversation analysis. J Homosex 2012;59:765-87.
QSR International. NVivo product range|QSR International [Internet]. 2017. Available at: http://www.qsrinternational.com/nvivo/nvivo-products (accessed 17 November 2017)
Columbia Care. Columbia Care [Internet]. 2018. Available at: https://www.col-care.com/ (accessed 22 November 2018)
GW Pharmaceuticals. Home|GW Pharmaceuticals, plc [Internet]. 2018. Available at: https://www.gwpharm.com/ (accessed 2 November 2018)
Weed for Good. Weed for Good | Weed for Good Provides Free Medical Cannabis and Education to Low Income Patients who are Suffering from Chronic and Terminal Illnesses [Internet]. 2019. Available at: http://weedforgood.org/ (accessed 27 November 2019)
Wiener. Bill Text - SB-34 Cannabis: Donations. [Internet]. 2019. Available at: https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200SB34 (accessed 27 November 2019)
KindColorado. KindColorado - KindColorado [Internet]. 2018. Available at: http://kindcolorado.org/ (accessed 2 November 2018)
Abrams D, Guzman M. Cannabis in cancer care. Clin Pharmacol Ther 2015;97:575-86.
Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse 2014;40:23-30.
FDA. Public Health Focus - FDA and Marijuana [Internet]. 2019. Available at: https://www.fda.gov/NewsEvents/PublicHealthFocus/ucm421163.htm (accessed 8 February 2019).
Millar JS. The corporate determinants of health: how big business affects our health, and the need for government action! Can J Public Health 2013;104:e327-9.
Wigand JS. Cigarette testing methods, product design, and labelling: time to clean up the “negative baggage”. 1998;
Kickbusch I, Allen L, Franz C. The commercial determinants of health. Lancet Glob Health 2016;4:e895-6.
Buse K, Tanaka S, Hawkes S. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. Glob Health 2017;13:34.
Adams PJ. Moral jeopardy: risks of accepting money from the alcohol, tobacco and gambling industries. Cambridge, UK: Cambridge University Press, 2016.
Hall W, Kozlowski LT. The diverging trajectories of cannabis and tobacco policies in the United States: reasons and possible implications: diverging trajectories of US cannabis and tobacco policies. Addiction 2018;113:595-601.
Hansen D, Maycock B, Lower T. ‘Weddings, parties, anything…’, a qualitative analysis of ecstasy use in Perth. Western Australia Int J Drug Policy 2001;12:181-99.
Harvey WS. Strategies for conducting elite interviews. Qual Res 2011;11:431-41.